Protagenic Therapeutics, Inc. (OTC:PTIX) Financings

Protagenic Therapeutics, Inc.

Financings

RaiseDate
Private placement of shares of common stock, pre-funded warrants and common warrants
Announced: US$1.5M–US$5M · two series of milestone-linked warrants that may provide up to $3.5 million in… · Brookline Capital Markets, a division of Arcadia Securities, LLC
Dealers: Brookline Capital Markets, a division of Arcadia Securities, LLC (lead)
Use of proceeds: Complete IND-enabling activities for PT00114, start its Phase 1/2a trial in Generalized Anxiety Disorder, and working capital and general corporate purposes
Nov 11, 2026

Read by 6ix AI from the company's releases